164 related articles for article (PubMed ID: 32406289)
1. An Industry Survey With Focus on Cardiovascular Safety Pharmacology Study Design and Data Interpretation.
Authier S; Abernathy MM; Correll K; Chui RW; Dalton J; Foley CM; Friedrichs GS; Koerner JE; Kallman MJ; Pannirselvam M; Redfern WS; Urmaliya V; Valentin JP; Wisialowski T; Zabka TS; Pugsley MK
Int J Toxicol; 2020; 39(4):274-293. PubMed ID: 32406289
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking safety pharmacology regulatory packages and best practice.
Lindgren S; Bass AS; Briscoe R; Bruse K; Friedrichs GS; Kallman MJ; Markgraf C; Patmore L; Pugsley MK
J Pharmacol Toxicol Methods; 2008; 58(2):99-109. PubMed ID: 18692579
[TBL] [Abstract][Full Text] [Related]
3. Proarrhythmia liability assessment and the comprehensive in vitro Proarrhythmia Assay (CiPA): An industry survey on current practice.
Authier S; Pugsley MK; Koerner JE; Fermini B; Redfern WS; Valentin JP; Vargas HM; Leishman DJ; Correll K; Curtis MJ
J Pharmacol Toxicol Methods; 2017 Jul; 86():34-43. PubMed ID: 28223123
[TBL] [Abstract][Full Text] [Related]
4. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies.
Benjamin A; Gallacher DJ; Greiter-Wilke A; Guillon JM; Kasai C; Ledieu D; Levesque P; Prelle K; Ratcliffe S; Sannajust F; Valentin JP
J Pharmacol Toxicol Methods; 2015; 75():101-10. PubMed ID: 25637943
[TBL] [Abstract][Full Text] [Related]
5. Methodological innovations expand the safety pharmacology horizon.
Pugsley MK; Curtis MJ
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):59-62. PubMed ID: 22617368
[TBL] [Abstract][Full Text] [Related]
6. Safety pharmacology in 2022: Taking one small step for cardiovascular safety assay development but one giant leap for regulatory drug safety assessment.
Pugsley MK; Koshman YE; de Korte T; Authier S; Winters BR; Curtis MJ
J Pharmacol Toxicol Methods; 2022; 117():107206. PubMed ID: 35926772
[TBL] [Abstract][Full Text] [Related]
7. Safety pharmacology investigations in toxicology studies: an industry survey.
Authier S; Vargas HM; Curtis MJ; Holbrook M; Pugsley MK
J Pharmacol Toxicol Methods; 2013; 68(1):44-51. PubMed ID: 23685201
[TBL] [Abstract][Full Text] [Related]
8. Statistical power analysis of cardiovascular safety pharmacology studies in conscious rats.
Bhatt S; Li D; Flynn D; Wisialowski T; Hemkens M; Steidl-Nichols J
J Pharmacol Toxicol Methods; 2016; 81():128-35. PubMed ID: 27071954
[TBL] [Abstract][Full Text] [Related]
9. Safety pharmacology investigations on the nervous system: An industry survey.
Authier S; Arezzo J; Delatte MS; Kallman MJ; Markgraf C; Paquette D; Pugsley MK; Ratcliffe S; Redfern WS; Stevens J; Valentin JP; Vargas HM; Curtis MJ
J Pharmacol Toxicol Methods; 2016; 81():37-46. PubMed ID: 27263834
[TBL] [Abstract][Full Text] [Related]
10. Twenty years of safety pharmacology model validation and the wider implications of this to drug discovery.
Pugsley MK; Bekele B; Griessel H; de Korte T; Authier S; Grobler AF; Markgraf CG; Curtis MJ
J Pharmacol Toxicol Methods; 2020 Sep; 105():106912. PubMed ID: 32798702
[TBL] [Abstract][Full Text] [Related]
11. Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiative.
Huang H; Pugsley MK; Fermini B; Curtis MJ; Koerner J; Accardi M; Authier S
J Pharmacol Toxicol Methods; 2017 Sep; 87():11-23. PubMed ID: 28408211
[TBL] [Abstract][Full Text] [Related]
12. In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity.
De Clerck F; Van de Water A; D'Aubioul J; Lu HR; van Rossem K; Hermans A; Van Ammel K
Fundam Clin Pharmacol; 2002 Apr; 16(2):125-40. PubMed ID: 12031065
[TBL] [Abstract][Full Text] [Related]
13. Recalibration of nonclinical safety pharmacology assessment to anticipate evolving regulatory expectations.
Pugsley MK; Authier S; Hayes ES; Hamlin RL; Accardi MV; Curtis MJ
J Pharmacol Toxicol Methods; 2016; 81():1-8. PubMed ID: 27343819
[TBL] [Abstract][Full Text] [Related]
14. Current Trends of Practices in Nonclinical Toxicology: An Industry Survey.
Authier S; Brock WJ; Halpern W; Harris SN; Jones D; McGovern T; McGovern PD; Pugsley MK
Int J Toxicol; 2021 Dec; 40(6):487-505. PubMed ID: 34569357
[TBL] [Abstract][Full Text] [Related]
15. How do the top 12 pharmaceutical companies operate safety pharmacology?
Ewart L; Gallacher DJ; Gintant G; Guillon JM; Leishman D; Levesque P; McMahon N; Mylecraine L; Sanders M; Suter W; Wallis R; Valentin JP
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):66-70. PubMed ID: 22510338
[TBL] [Abstract][Full Text] [Related]
16. CiPA challenges and opportunities from a non-clinical, clinical and regulatory perspectives. An overview of the safety pharmacology scientific discussion.
Wallis R; Benson C; Darpo B; Gintant G; Kanda Y; Prasad K; Strauss DG; Valentin JP
J Pharmacol Toxicol Methods; 2018; 93():15-25. PubMed ID: 29958940
[TBL] [Abstract][Full Text] [Related]
17. Social housing of non-rodents during cardiovascular recordings in safety pharmacology and toxicology studies.
Prior H; Bottomley A; Champéroux P; Cordes J; Delpy E; Dybdal N; Edmunds N; Engwall M; Foley M; Hoffmann M; Kaiser R; Meecham K; Milano S; Milne A; Nelson R; Roche B; Valentin JP; Ward G; Chapman K
J Pharmacol Toxicol Methods; 2016; 81():75-87. PubMed ID: 27039257
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive in vitro Proarrhythmia Assay (CiPA): Pending issues for successful validation and implementation.
Cavero I; Guillon JM; Ballet V; Clements M; Gerbeau JF; Holzgrefe H
J Pharmacol Toxicol Methods; 2016; 81():21-36. PubMed ID: 27233533
[TBL] [Abstract][Full Text] [Related]
19. Methods in safety pharmacology in focus.
Pugsley MK; Gallacher DJ; Towart R; Authier S; Curtis MJ
J Pharmacol Toxicol Methods; 2008; 58(2):69-71. PubMed ID: 18707009
[TBL] [Abstract][Full Text] [Related]
20. Non-clinical evaluation of ventricular repolarization (ICH S7B): results of an interim survey of international pharmaceutical companies.
Friedrichs GS; Patmore L; Bass A
J Pharmacol Toxicol Methods; 2005; 52(1):6-11. PubMed ID: 15975833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
